High throughput sequencing of multiple transcripts

US9708654B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9708654-B2
Application numberUS-201314407849-A
CountryUS
Kind codeB2
Filing dateJun 17, 2013
Priority dateJun 15, 2012
Publication dateJul 18, 2017
Grant dateJul 18, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure generally relates to sequencing two or more genes expressed in a single cell in a high-throughput manner. More particularly, the present disclosure relates to a method for high-throughput sequencing of pairs of transcripts co expressed in single cells (e.g., antibody VH and VL coding sequence) to determine pairs of polypeptide chains that comprise immune receptors.

First claim

Opening claim text (preview).

What is claimed is: 1. A method comprising: a) sequestering single cells and an mRNA capture agent into individual compartments; b) lysing the cells and collecting mRNA transcripts with the mRNA capture agent; c) isolating the mRNA from the compartments using the mRNA capture agent; d) performing reverse transcription followed by PCR amplification on the captured mRNA; and e) sequencing at least two distinct cDNA products amplified from a single cell, wherein: (i) the at least two distinct cDNA products comprise paired antibody VH and VL sequences, wherein the cells are B-cells; or (ii) the at least two distinct cDNA products comprise paired T-cell receptor sequences, wherein the cells are T-cells. 2. The method of claim 1 , wherein the at least two distinct cDNA products comprise paired antibody VH and VL sequences, wherein the cells are B-cells. 3. The method of claim 1 , wherein the mRNA capture agent is a bead. 4. The method of claim 3 , wherein the beads are magnetic. 5. The method of claim 3 , wherein the bead comprises oligonucleotides which hybridize mRNA. 6. The method of claim 5 , wherein the oligonucleotides comprise at least one of poly(T) and primers specific to a transcript of interest. 7. The method of claim 2 , wherein the paired antibody VH and VL sequences are for an antibody that binds to an antigen of interest. 8. The method of claim 5 , wherein the beads are conjugated to an antigen of interest and the oligonucleotides are only conjugated to the beads in the presence of an antibody that binds to the antigen of interest. 9. The method of claim 1 , wherein the individual compartments are wells in a gel or microtiter plate. 10. The method of claim 1 , said individual compartments having a volume of less than 5 nL. 11. The method of claim 10 , wherein the compartments are sealed with a permeable membrane prior to step (c). 12. The method of claim 1 , wherein the individual compartments are microvesicles in an emulsion. 13. The method of claim 1 , wherein steps (a) and (b) are performed concurrently. 14. The method of claim 1 , wherein steps (a) and (b) comprise isolating single cells and an mRNA capture agent into individual microvesicles in an emulsion and in the presence of a cell lysis solution. 15. The method of claim 2 , comprising obtaining sequences from at least 10,000 individual cells or at least 5,000 individual paired antibody VH and VL sequences. 16. The method of claim 1 , wherein step (e) comprises: linking VH and VL cDNAs by performing overlap extension reverse transcriptase polymerase chain reaction to link VH and VL cDNAs in single DNA molecules, wherein the at least two distinct cDNA products comprise paired antibody VH and VL sequences. 17. The method of claim 1 , wherein step (e) does not comprise the use of overlap extension reverse transcriptase polymerase chain reaction. 18. The method of claim 2 , wherein the VH and VL sequences are obtained by sequencing of distinct molecules. 19. The method of claim 1 , wherein the at least two distinct cDNA products comprise paired T-cell receptor sequences, wherein the cells are T-cells. 20. The method of claim 1 , wherein step (e) comprises linking cDNA by performing overlap extension reverse transcriptase polymerase chain reaction to link at least 2 transcripts into a single DNA molecule.

Assignees

Inventors

Classifications

  • Handling flowable solids, e.g. microscopic beads, cells, particles · CPC title

  • C12Q1/6869Primary

    Methods for sequencing · CPC title

  • C12Q1/6806Primary

    Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • specially adapted for droplet or plug flow, e.g. digital microfluidics · CPC title

  • by coupling phenotype to genotype, not provided for in other groups of this subclass · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9708654B2 cover?
The present disclosure generally relates to sequencing two or more genes expressed in a single cell in a high-throughput manner. More particularly, the present disclosure relates to a method for high-throughput sequencing of pairs of transcripts co expressed in single cells (e.g., antibody VH and VL coding sequence) to determine pairs of polypeptide chains that comprise immune receptors.
Who is the assignee on this patent?
Univ Texas, Univ Texas
What technology area does this patent fall under?
Primary CPC classification C12Q1/6869. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).